Table of Contents
Problems and Issues with Implementation of FDAMA and the Final Rule - April 3, 2000
PPT Slide
PPT Slide
2 Major Approaches
Key Elements
Final Rule vs. FDAMA
Final Rule vs. FDAMA
Final Rule vs. FDAMA
PPT Slide
FDAMA Activity As of March 1, 2000
2000
Pediatric Drug Development Problems and Issues
Pediatric Drug Development Solutions 2000
Written Requests Neurology
Psychotropic Drugs for which FDA has Requested Studies in Children As of 3/1/00
Psychotropic Drugs: Current Labeling
Psychotropic Drugs: Current Labeling
Pediatric Drug Development Solutions 2000
Pediatric Drug Development Solutions 2000
Pediatric Drug Development Solutions 2000
Pediatric Drug Development Solutions 2000
Pediatric Drug Development Solutions 2000
Pediatric Drug Development Solutions 2000
Pediatric Drug Development Solutions 2000
Pediatric Drug Development Solutions 2000
Pediatric Drug Development Solutions 2000
Pediatric Drug Development Solutions 2000
Pediatric Drug Development Solutions 2000
Pediatric Drug Development Solutions 2000
Pediatric Drug Development Solutions 2000
To Find out More |
Author: Dianne Murphy, MD, Associate Director for Pediatrics
Download presentation source |
